Moleculin Stock Price History Breakdown

MBRX
 Stock
  

USD 1.62  0.01  0.61%   

As of today, the current price of Moleculin Biotech is  1.62 , as last reported on the 15th of August 2022, with the highest price reaching  1.65  and the lowest price hitting  1.62  during the day.
Moleculin Biotech appears to be slightly risky, given 3 months investment horizon. Moleculin Biotech has Sharpe Ratio of 0.1, which conveys that the firm had 0.1% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Moleculin Biotech, which you can use to evaluate the future volatility of the firm. Please exercise Moleculin Biotech's Risk Adjusted Performance of 0.1311, downside deviation of 3.71, and Mean Deviation of 2.82 to check out if our risk estimates are consistent with your expectations.
  
Net Income Common Stock is likely to drop to about (16.3 M) in 2022. Moleculin Biotech Price to Book Value is fairly stable at the moment as compared to the past year. Moleculin Biotech reported Price to Book Value of 0.67 in 2021. Price to Sales Ratio is likely to rise to 5.88 in 2022, whereas Price to Earnings Ratio are likely to drop (3.40)  in 2022. Moleculin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
27.9 M
Shares Outstanding
28.6 M
Shares Short Prior Month
118.2 K
Earnings Share
-0.64
Shares Short
53.5 K

Moleculin Biotech August 15, 2022 Stock Price Synopsis

Moleculin Biotech Price Rate Of Daily Change 0.99 
Moleculin Biotech Price Daily Balance Of Power(0.33) 
Moleculin Biotech Price Action Indicator(0.02) 
Moleculin Biotech Accumulation Distribution 884.69 

Moleculin Biotech August 15, 2022 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Moleculin Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Moleculin Biotech intraday prices and daily technical indicators to check the level of noise trading in Moleculin Stock and then apply it to test your longer-term investment strategies against Moleculin.

Moleculin Biotech Stock Price History Chart

There are several ways to analyze Moleculin Stock price data. The simplest method is using a basic Moleculin candlestick price chart, which shows Moleculin Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

90 Days Highest PriceJuly 21, 20221.9
90 Days Lowest PriceMay 19, 20221.29

Moleculin Stock Price History Data

The price series of Moleculin Biotech for the period between Tue, May 17, 2022 and Mon, Aug 15, 2022 has a statistical range of 0.71 with a coefficient of variation of 11.35. The daily prices for the period are spread out with arithmetic mean of 1.54. The median price for the last 90 days is 1.51. The company underwent null stock split on 1st of February 2021.
OpenHighLowCloseVolume
08/12/2022 1.62  1.65  1.62  1.62  48,658 
08/11/2022 1.71  1.75  1.57  1.63  203,255 
08/10/2022 1.71  1.78  1.70  1.71  32,453 
08/09/2022 1.76  1.79  1.68  1.68  31,888 
08/08/2022 1.67  1.78  1.67  1.73  64,831 
08/05/2022 1.70  1.73  1.67  1.70  41,154 
08/04/2022 1.61  1.73  1.61  1.71  47,190 
08/03/2022 1.66  1.68  1.63  1.63  26,960 
08/02/2022 1.68  1.69  1.61  1.63  80,921 
08/01/2022 1.65  1.69  1.65  1.67  13,664 
07/29/2022 1.72  1.73  1.67  1.69  40,404 
07/28/2022 1.64  1.71  1.64  1.70  17,860 
07/27/2022 1.73  1.73  1.63  1.69  35,139 
07/26/2022 1.66  1.77  1.66  1.74  41,013 
07/25/2022 1.84  1.87  1.71  1.71  75,997 
07/22/2022 1.90  1.90  1.84  1.89  46,966 
07/21/2022 1.90  1.91  1.86  1.90  23,005 
07/20/2022 1.94  1.94  1.85  1.88  52,803 
07/19/2022 1.73  1.90  1.72  1.87  213,846 
07/18/2022 1.72  1.75  1.69  1.69  76,780 
07/15/2022 1.73  1.73  1.63  1.65  16,869 
07/14/2022 1.75  1.75  1.61  1.68  43,199 
07/13/2022 1.62  1.73  1.62  1.69  26,483 
07/12/2022 1.65  1.69  1.63  1.64  23,782 
07/11/2022 1.75  1.75  1.66  1.68  14,113 
07/08/2022 1.59  1.75  1.59  1.69  43,632 
07/07/2022 1.63  1.70  1.61  1.69  23,182 
07/06/2022 1.55  1.71  1.52  1.65  69,040 
07/05/2022 1.41  1.55  1.41  1.53  46,835 
07/01/2022 1.42  1.53  1.42  1.47  22,615 
06/30/2022 1.45  1.54  1.43  1.45  58,362 
06/29/2022 1.45  1.51  1.44  1.50  13,126 
06/28/2022 1.50  1.52  1.45  1.47  25,966 
06/27/2022 1.50  1.51  1.44  1.49  41,508 
06/24/2022 1.41  1.48  1.41  1.46  46,939 
06/23/2022 1.40  1.44  1.38  1.39  34,200 
06/22/2022 1.40  1.46  1.38  1.42  37,939 
06/21/2022 1.50  1.50  1.40  1.45  61,697 
06/17/2022 1.31  1.49  1.31  1.49  67,975 
06/16/2022 1.36  1.39  1.26  1.33  51,731 
06/15/2022 1.37  1.43  1.35  1.39  26,757 
06/14/2022 1.37  1.39  1.34  1.39  31,561 
06/13/2022 1.39  1.46  1.30  1.34  106,000 
06/10/2022 1.48  1.52  1.44  1.50  45,463 
06/09/2022 1.49  1.54  1.49  1.49  28,144 
06/08/2022 1.44  1.55  1.44  1.53  30,168 
06/07/2022 1.46  1.54  1.41  1.47  48,286 
06/06/2022 1.52  1.55  1.47  1.48  44,114 
06/03/2022 1.44  1.55  1.44  1.53  37,413 
06/02/2022 1.48  1.55  1.47  1.48  34,392 
06/01/2022 1.52  1.55  1.43  1.51  21,971 
05/31/2022 1.50  1.54  1.43  1.50  60,979 
05/27/2022 1.48  1.55  1.41  1.51  67,297 
05/26/2022 1.38  1.46  1.38  1.44  54,954 
05/25/2022 1.36  1.41  1.32  1.39  50,435 
05/24/2022 1.31  1.36  1.27  1.33  34,453 
05/23/2022 1.32  1.40  1.31  1.32  20,971 
05/20/2022 1.33  1.37  1.29  1.31  45,979 
05/19/2022 1.27  1.39  1.26  1.29  101,426 
05/18/2022 1.32  1.38  1.27  1.30  53,561 

About Moleculin Biotech Stock history

Moleculin Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moleculin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moleculin Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moleculin Biotech historical stock prices may prove useful in developing a viable investing in Moleculin Biotech
Last ReportedProjected for 2022
Weighted Average Shares26.9 M29 M
Weighted Average Shares Diluted26.9 M29 M
Issuance Purchase of Equity Shares74.7 M80.6 M
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas. Moleculin Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Moleculin Biotech Quarterly Market Capitalization

41.44 Million

Moleculin Biotech Stock Technical Analysis

Moleculin Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Moleculin Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Moleculin Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Moleculin Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Moleculin stock's direction in advance. Along with the technical and fundamental analysis of Moleculin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moleculin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Additionally, see Stocks Correlation. Note that the Moleculin Biotech information on this page should be used as a complementary analysis to other Moleculin Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Moleculin Stock analysis

When running Moleculin Biotech price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Moleculin Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moleculin Biotech. If investors know Moleculin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moleculin Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
46.3 M
Return On Assets
-0.19
Return On Equity
-0.28
The market value of Moleculin Biotech is measured differently than its book value, which is the value of Moleculin that is recorded on the company's balance sheet. Investors also form their own opinion of Moleculin Biotech's value that differs from its market value or its book value, called intrinsic value, which is Moleculin Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moleculin Biotech's market value can be influenced by many factors that don't directly affect Moleculin Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moleculin Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Moleculin Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moleculin Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.